Kazia Therapeutics (KZIA) Income from Continuing Operations (2009 - 2011)

Kazia Therapeutics has reported Income from Continuing Operations for 3 years, with the latest figure at 926122.02 in Q4 2011.

• For the quarter ending Q4 2011, Income from Continuing Operations rose 81.99% year-over-year to 926122.02; the trailing twelve-month figure through Dec 2011 stood at 19837935.9 (up 35.14% YoY), and the FY2025 full-year result was 13258248.17, up 24.87% from the prior year.
• Income from Continuing Operations for Q4 2011 stood at 926122.02, up from 5142472.41 in the prior quarter.
• The five-year high for Income from Continuing Operations was 926122.02 in Q4 2011, with the low at 5811839.7 in Q4 2009.
• Historically, Income from Continuing Operations has averaged 3960144.71 across 3 years, with a median of 5142472.41 in 2010.
• Annual changes were most pronounced in 2010 — Income from Continuing Operations gained 11.52% — and 2011, when it surged 81.99%.
• Kazia Therapeutics' Income from Continuing Operations stood at 5811839.7 in 2009, then advanced by 11.52% to 5142472.41 in 2010, then surged by 81.99% to 926122.02 in 2011.
• The last three Income from Continuing Operations figures came in at 926122.02 (Q4 2011), 5142472.41 (Q4 2010), and 5811839.7 (Q4 2009), per Business Quant data.